David Domzalski
CIK 1727794 · PRESIDENT AND CEO · last filed 2026-06-02
David Domzalski is a PRESIDENT AND CEO who has filed 66 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider was granted $9.5K of VYNE on Jun 2, 2026. Across all open-market trades the lifetime net is −$10.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $284.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$284.5K
3
66
-$10.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYNE | PRESIDENT AND CEO | 438,779 | $0.65 | $284.5K | $103.6K | 40 | 2026-06-02 |
| VYNE Therapeutics Inc. (MNLO) Delisted | President and CEO | 1,240,966 | — | — | $0 | 5 | 2020-07-02 |
| Foamix Pharmaceuticals Ltd. (FOMX) Delisted | CEO | 324,028 | — | — | -$113.9K | 20 | 2020-03-03 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | VYNE | Grant (A) | +30,791 | $9.5K | EDGAR |
| 2026-04-02 | VYNE | Tax (F) | −14,232 | -$8.5K | EDGAR |
| 2026-01-05 | VYNE | Tax (F) | −12,684 | -$7.4K | EDGAR |
| 2025-10-02 | VYNE | Tax (F) | −12,676 | -$4.2K | EDGAR |
| 2025-07-02 | VYNE | Tax (F) | −12,676 | -$20.9K | EDGAR |
| 2025-06-03 | VYNE | Grant (A) | +8,681 | $7.0K | EDGAR |
| 2025-04-02 | VYNE | Tax (F) | −30,498 | -$48.2K | EDGAR |
| 2025-01-23 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2025-01-02 | VYNE | Tax (F) | −24,536 | -$82.2K | EDGAR |
| 2024-12-03 | VYNE | Grant (A) | +3,901 | $8.2K | EDGAR |